Published in J Cell Sci on June 01, 2001
Cell mechanics control rapid transitions between blebs and lamellipodia during migration. Proc Natl Acad Sci U S A (2012) 1.67
Talin B is required for force transmission in morphogenesis of Dictyostelium. EMBO J (2004) 1.10
Bleb-driven chemotaxis of Dictyostelium cells. J Cell Biol (2014) 1.06
How blebs and pseudopods cooperate during chemotaxis. Proc Natl Acad Sci U S A (2014) 0.89
Dictyostelium cell death: early emergence and demise of highly polarized paddle cells. J Cell Biol (2003) 0.87
The exocytic gene secA is required for Dictyostelium cell motility and osmoregulation. J Cell Sci (2010) 0.80
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (1992) 2.06
Three mutant insulins in man. Nature (1983) 1.40
Synthesis of (Pro-Hyp-Gly) n of defined molecular weights. Evidence for the stabilization of collagen triple helix by hydroxypyroline. Biochim Biophys Acta (1973) 1.37
New synthetic substrates for pepsin. Biochemistry (1966) 1.26
Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile. Life Sci (1984) 1.22
Studies on the specificity of pepsin. Biochemistry (1967) 1.22
Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur J Biochem (2000) 1.21
The inhibition of pepsin action. Biochemistry (1968) 1.20
Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett (1990) 1.16
Regulation of movement speed by intracellular pH during Dictyostelium discoideum chemotaxis. Proc Natl Acad Sci U S A (1991) 1.15
Oscillations of membrane potential in L cells. I. Basic characteristics. J Membr Biol (1977) 1.15
Motive force of the migrating pseudoplasmodium of the cellular slime mould Dictyostelium discoideum. J Cell Sci (1980) 1.09
A unique talin homologue with a villin headpiece-like domain is required for multicellular morphogenesis in Dictyostelium. Curr Biol (1999) 1.02
Metabolism of vitamin D(3) by human CYP27A1. Biochem Biophys Res Commun (2000) 1.01
Myopathology of hypothyroid myopathy. Some new observations. J Neurol Sci (1987) 1.00
Effects of the stereo-configuration of the hydroxyl group in 4-hydroxyproline on the triple-helical structures formed by homogenous peptides resembling collagen. Biochim Biophys Acta (1976) 1.00
Semisynthesis and properties of some insulin analogs. Biopolymers (1981) 1.00
Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol (2003) 1.00
No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation. J Clin Endocrinol Metab (1999) 0.99
Single-step purification of F(ab')2 fragments of mouse monoclonal antibodies (immunoglobulins G1) by hydrophobic interaction high performance liquid chromatography using TSKgel Phenyl-5PW. J Biochem Biophys Methods (1992) 0.98
Synthesis and physical properties of (hydroxyproline-proline-glycine)10: hydroxyproline in the X-position decreases the melting temperature of the collagen triple helix. Arch Biochem Biophys (1982) 0.97
Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity. Biochem J (1982) 0.96
Pepsin as an esterase. J Am Chem Soc (1967) 0.96
Refolding and recovery of recombinant human matrix metalloproteinase 7 (matrilysin) from inclusion bodies expressed by Escherichia coli. J Biochem (1999) 0.94
Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha,25-dihydroxyvitamin D3 to calcitroic acid. Eur J Biochem (1999) 0.92
Measurements of intracellular pH and its relevance to cell differentiation in Dictyostelium discoideum. J Cell Sci (1985) 0.92
Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin. Experientia (1981) 0.91
Involvement of B-Raf in Ras-induced Raf-1 activation. FEBS Lett (2001) 0.91
Effects of antecedent hypoglycemia, hyperinsulinemia, and excess corticosterone on hypoglycemic counterregulation. Am J Physiol Endocrinol Metab (2001) 0.90
Total synthesis of a natural antioxidant and structure-activity relationships of related compounds. Chem Pharm Bull (Tokyo) (1999) 0.90
Formation of crystals of the insecticidal proteins of Bacillus thuringiensis subsp. aizawai IPL7 in Escherichia coli. J Bacteriol (1989) 0.89
Correlations between prestalk-prespore tendencies and cAMP-related activities in Dictyostelium discoideum. Exp Cell Res (1982) 0.89
Preparation and evaluation of intragastric buoyant preparations. Drug Des Deliv (1989) 0.89
Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment. Endocrinology (2001) 0.89
Purification of monoclonal antibodies with light-chain heterogeneity produced by mouse hybridomas raised with NS-1 myelomas: application of hydrophobic interaction high-performance liquid chromatography. J Biochem Biophys Methods (1993) 0.89
"Ragged-red" fibres in myotonic dystrophy. J Neurol Sci (1986) 0.88
Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma. Clin Chem (1998) 0.87
Purification and characterization of immunoglobulin production stimulating factor derived from human B lymphoblastoid HO-323 cells. Cytotechnology (1990) 0.87
Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin. Biochem Biophys Res Commun (1984) 0.85
Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics. Biochemistry (1989) 0.85
Effects of caerulein-related peptides on cholecystokinin receptor bindings in brain and pancreas. Biochem Pharmacol (1985) 0.84
Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors. Biochem Biophys Res Commun (1982) 0.84
Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor. J Biochem (1993) 0.83
Separation of some polypeptide hormones by high-performance liquid chromatography. J Chromatogr (1979) 0.83
Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). Eur J Biochem (2001) 0.83
Lysyl-tRNA synthetase from Bacillus stearothermophilus. Purification, and fluorometric and kinetic analysis of the binding of substrates, L-lysine and ATP. J Biochem (1996) 0.83
Stability of human atrial natriuretic peptide in blood samples. Clin Chim Acta (1994) 0.83
Potassium ion-induced swelling of nerve-ending particles by light-scattering measurement. Biochim Biophys Acta (1973) 0.82
Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. Proc Natl Acad Sci U S A (1993) 0.82
Regulatory role of atrial natriuretic polypeptide in water drinking in rats. Eur J Pharmacol (1986) 0.82
Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: species-specific actions of BNP. Biochem Biophys Res Commun (1990) 0.81
Insulin Wakayama: familial mutant insulin syndrome in Japan. Diabetologia (1987) 0.81
Effects of cobalt-substitution of the active zinc ion in thermolysin on its activity and active-site microenvironment. J Biochem (2001) 0.81
Enzymatic properties of mouse 25-hydroxyvitamin D3 1 alpha-hydroxylase expressed in Escherichia coli. Eur J Biochem (1999) 0.81
Distribution, structure, organ-specific expression, and phylogenic analysis of the pathogenesis-related protein-3 chitinase gene family in rice (Oryza sativa L.). Genome (2006) 0.80
The stoichiometry of inhibition and binding of a protein proteinase inhibitor from Streptomyces (Streptomyces subtilisin inhibitor) against subtilisin BPN'1. J Biochem (1977) 0.80
Lysyl-tRNA synthetase from Bacillus stearothermophilus. Stopped-flow kinetic analysis of enzyme.lysyladenylate formation. J Biochem (1998) 0.80
Enzymatic properties of human 25-hydroxyvitamin D3 1alpha-hydroxylase coexpression with adrenodoxin and NADPH-adrenodoxin reductase in Escherichia coli. Eur J Biochem (1999) 0.80
Active site of trypsin-like enzyme from Streptomyces erythreus. Specific inactivation by new chloromethyl ketones derived from Na-dinitrophenyl-L-lysine and Na-tosyl-L-arginine. Biochim Biophys Acta (1973) 0.80
The states of tyrosyl and tryptophyl residues in a protein proteinase inhibitor (Streptomyces subtilisin inhibitor. J Biochem (1977) 0.79
Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin. Diabetes (1985) 0.79
The syntheses of peptides related to the N-terminal structure of corticotropin. VII. The synthesis of peptide derivatives corresponding to positions 11 to 18 in the corticotropin molecule. Bull Chem Soc Jpn (1966) 0.79
Mutant insulin syndrome: identification of two families with [LeuA3]insulin and determination of its biological activity. Trans Assoc Am Physicians (1986) 0.79
Investigation of the formation of triple helices between (Pro-Pro-Gly)n's of different degrees of polymerization using gel filtration. Biopolymers (1977) 0.78
Synthesis and biological properties of two dimeric forms of human alpha-atrial natriuretic peptide. FEBS Lett (1986) 0.78
Properties of the tryptophan residue in rabbit liver microsomal cytochrome P-450 isozyme 2 as determined by fluorescence. Biochem Biophys Res Commun (1985) 0.77
Analysis of three tissue-specific elements from the wheat Cab-1 enhancer. Plant J (1993) 0.77
Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin. Biochem Biophys Res Commun (1986) 0.77
Practical application of mammalian cytochrome P450. J Biosci Bioeng (2000) 0.77
A voltage- and K+-dependent K+ channel from a membrane fraction enriched in contractile vacuole of Dictyostelium discoideum. Biochim Biophys Acta (1997) 0.77
Further studies on the interaction between a protein proteinase inhibitor, Streptomyces subtilisin inhibitor, and thiolsubtilisin BPN'. J Biochem (1979) 0.77
Bacillus thuringiensis serovar shandongiensis strain 89-T-34-22 produces multiple cytotoxic proteins with similar molecular masses against human cancer cells. Lett Appl Microbiol (2004) 0.77
Effect of a novel tachykinin, substance K, on salivation in rats. Eur J Pharmacol (1985) 0.77
A sensitive enzyme immunoassay of human thyroid-stimulating hormone (TSH) using bispecific F(ab')2 fragments recognizing polymerized alkaline phosphatase and TSH. J Immunol Methods (1997) 0.77
A dicarba analog of beta-atrial natriuretic peptide (beta-ANP) inhibits guanosine 3',5'-cyclic monophosphate production induced by alpha-ANP in cultured rat vascular smooth muscle cells. FEBS Lett (1989) 0.77
Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase. Biochem Biophys Res Commun (1999) 0.77
Interactions of human matrix metalloproteinase 7 (matrilysin) with the inhibitors thiorphan and R-94138. J Biochem (2001) 0.77
Cellular uptake and biological effects of antisense oligodeoxynucleotide analogs targeted to herpes simplex virus. Antimicrob Agents Chemother (1996) 0.77
Mutational effect for stability in a conserved region of thermolysin. Lett Appl Microbiol (2005) 0.77
Inhibition of cytochrome P-450-linked monooxygenase systems by naphthoquinones. Biochem Biophys Res Commun (1987) 0.76
Lysyl-tRNA synthetase from Bacillus stearothermophilus. Formation and isolation of an enzyme-lysyladenylate complex and its analogue. J Biochem (1997) 0.76
[The effects of lysozyme chloride on the immune response of patients with head and neck cancer]. Gan No Rinsho (1987) 0.76
Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. Arch Biochem Biophys (2000) 0.76
The interaction of a tyrosyl residue and carboxyl groups in the specific interaction between Streptomyces subtilisin inhibitor and subtilisin BPN'. A chemical modification study. J Biochem (1979) 0.76
The states of tyrosyl residues in thermolysin as examined by nitration and pH-dependent ionization. J Biochem (1997) 0.76
Effects of dimethyl sulfoxide, temperature, and sodium chloride on the activity of human matrix metalloproteinase 7 (matrilysin). J Biochem (2000) 0.76
Flow cytometric analysis of sialyl Lewis A antigen on human cancer cells by using F(ab')2μ fragments prepared from a mouse IgM monoclonal antibody. Cytotechnology (1997) 0.75
Structure-activity relationships of adrenocorticotropin. Pharmacol Ther B (1975) 0.75
Deletion of the κ genes from mouse hybridomas established with NS-1 myelomas. Cytotechnology (1997) 0.75
[Preparation of F(ab')2 mu fragments of IgM monoclonal antibodies]. Seikagaku (1996) 0.75
New hapten-protein conjugation method using N-(m-aminobenzoyloxy) succinimide as a two-level heterobifunctional agent: thyrotropin-releasing hormone as a model peptide without free amino or carboxyl groups. J Immunol Methods (1994) 0.75
The synthesis of a heptadecapeptide amide corresponding to a modified sequence in the corticotropin structure. Bull Chem Soc Jpn (1965) 0.75
The use of N-(aminobenzoyloxy) succinimide as a two-level heterobifunctional agent for the preparation of hapten-protein conjugates. Daunomycin as a model hapten with an amino group. J Immunol Methods (1990) 0.75
[Brief counting method of airborne Cryptomeria japonica pollen by a combination of fluorescence antibody staining and flow cytometry]. Arerugi (1992) 0.75
A highly specific and sensitive radioimmunoassay of caerulein, an analogue of cholecystokinin-8. J Immunoassay (1988) 0.75
Development of a new protein- and hormone-free medium for hybridoma cultivation. Agric Biol Chem (1991) 0.75
Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat. Peptides (1989) 0.75
Subpicosecond accumulated photon echoes using a continuous-wave multimode diode laser. Opt Lett (1989) 0.75
Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues. J Biochem (1993) 0.75